Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 979

1.

The Japan Marrow Donor Program, 25 years of experience in achieving 20,000 bone marrow transplantations: organization structure, activity, and financial basis.

Saito H, Ito M, Kato S, Kodera Y, Okamoto S, Taniguchi S, Takanashi M, Kanamori H, Masaoka T, Takaku F; JMDP.

Bone Marrow Transplant. 2018 May;53(5):609-616. doi: 10.1038/s41409-017-0084-2. Epub 2018 Jan 24.

PMID:
29367710
2.

Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes.

Kobayashi S, Ueda Y, Nannya Y, Shibayama H, Tamura H, Ogata K, Akatsuka Y, Usuki K, Ito Y, Okada M, Suzuki T, Hata T, Matsuda A, Tohyama K, Kakumoto K, Koga D, Mitani K, Naoe T, Sugiyama H, Takaku F.

Cancer Biomark. 2016 Mar 31;17(1):21-32. doi: 10.3233/CBM-160612.

PMID:
27062571
3.

Clinical usefulness of WT1 mRNA expression in bone marrow detected by a new WT1 mRNA assay kit for monitoring acute myeloid leukemia: a comparison with expression of WT1 mRNA in peripheral blood.

Kitamura K, Nishiyama T, Ishiyama K, Miyawaki S, Miyazaki K, Suzuki K, Masaie H, Okada M, Ogawa H, Imai K, Kiyoi H, Naoe T, Yokoyama Y, Chiba S, Hata T, Miyazaki Y, Hatta Y, Takeuchi J, Nannya Y, Kurokawa M, Ueda Y, Koga D, Sugiyama H, Takaku F.

Int J Hematol. 2016 Jan;103(1):53-62. doi: 10.1007/s12185-015-1882-1. Epub 2015 Oct 31.

PMID:
26520650
4.

Closing address.

Takaku F.

Japan Med Assoc J. 2014 Feb 1;57(1):36. No abstract available.

5.

Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes.

Ueda Y, Mizutani C, Nannya Y, Kurokawa M, Kobayashi S, Takeuchi J, Tamura H, Ogata K, Dan K, Shibayama H, Kanakura Y, Niimi K, Sasaki K, Watanabe M, Emi N, Teramura M, Motoji T, Kida M, Usuki K, Takada S, Sakura T, Ito Y, Ohyashiki K, Ogawa H, Suzuki T, Ozawa K, Imai K, Kasai M, Hata T, Miyazaki Y, Morita Y, Kanamaru A, Matsuda A, Tohyama K, Koga D, Tamaki H, Mitani K, Naoe T, Sugiyama H, Takaku F.

Leuk Lymphoma. 2013 Jul;54(7):1450-8. doi: 10.3109/10428194.2012.745074. Epub 2012 Nov 26.

PMID:
23110324
6.

Differences in blast immunophenotypes among disease types in myelodysplastic syndromes: a multicenter validation study.

Ogata K, Kakumoto K, Matsuda A, Tohyama K, Tamura H, Ueda Y, Kurokawa M, Takeuchi J, Shibayama H, Emi N, Motoji T, Miyazaki Y, Tamaki H, Mitani K, Naoe T, Sugiyama H, Takaku F.

Leuk Res. 2012 Oct;36(10):1229-36. doi: 10.1016/j.leukres.2012.05.006. Epub 2012 Jun 7.

PMID:
22682984
7.

A multicenter randomized, double-blind, placebo-controlled late-phase II/III study of recombinant human interleukin 11 in acute myelogenous leukemia.

Usuki K, Urabe A, Ikeda Y, Ohashi Y, Mizoguchi H, Takaku F; Japan IL-11 Study Group.

Int J Hematol. 2007 Jan;85(1):59-69.

PMID:
17261503
8.

Stable response after administration of stem cell factor combined with granulocyte colony-stimulating factor in aplastic anemia.

Usuki K, Iki S, Arai S, Iijima K, Takaku F, Urabe A.

Int J Hematol. 2006 Jun;83(5):404-7.

PMID:
16787870
9.

International Consensus Conference on Bone Marrow Failure Syndromes: review and recommendations.

Omine M, Kojima S, Nakao S, Mizoguchi H, Takaku F.

Int J Hematol. 2005 Dec;82(5):406-7. No abstract available.

PMID:
16533742
10.

[Clinical course of the disease and the level of WT1 mRNA in 191 patients with acute myeloid leukemia (AML): joint research by 23 institutions in Japan].

Miyawaki S, Emi N, Mitani K, Oyashiki K, Kitamura K, Morishita T, Ogawa H, Komatsu N, Soma T, Tamaki T, Kosugi H, Ohnishi K, Mizoguchi H, Hiraoka A, Kodera Y, Ueda R, Morishima Y, Nakagawa M, Tobita T, Sugimoto K, Chiba S, Inoue N, Hamaguchi M, Koga D, Tamaki H, Naoe T, Sugiyama H, Takaku F.

Rinsho Ketsueki. 2005 Dec;46(12):1279-87. Japanese.

PMID:
16447800
11.

Improved gene expression in resting macrophages using an oligopeptide derived from Vpr of human immunodeficiency virus type-1.

Mizoguchi I, Ooe Y, Hoshino S, Shimura M, Kasahara T, Kano S, Ohta T, Takaku F, Nakayama Y, Ishizaka Y.

Biochem Biophys Res Commun. 2005 Dec 23;338(3):1499-506. Epub 2005 Oct 27.

PMID:
16274667
12.

[An early phase II clinical study of YM 294 (rhlL-11) in patients with solid tumors and malignant lymphoma].

Hatae M, Ariyoshi Y, Fukuoka M, Furuse K, Noda K, Hirabayashi K, Yakushiji M, Ogawa M, Takaku F.

Gan To Kagaku Ryoho. 2005 Apr;32(4):489-96. Japanese.

PMID:
15853215
13.

[A clinical study of YM 294 (rhlL-11) in patients with gynecologic cancer].

Hatae M, Noda K, Yamamoto K, Ozaki M, Hirabayashi K, Nishida T, Ohashi Y, Ogawa M, Takaku F.

Gan To Kagaku Ryoho. 2005 Apr;32(4):479-87. Japanese.

PMID:
15853214
14.

Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma.

Mori M, Kitamura K, Masuda M, Hotta T, Miyazaki T, Miura AB, Mizoguchi H, Shibata A, Saito H, Matsuda T, Masaoka T, Harada M, Niho Y, Takaku F.

Int J Hematol. 2005 Apr;81(3):246-54.

PMID:
15814336
15.

Nuclear trafficking of macromolecules by an oligopeptide derived from Vpr of human immunodeficiency virus type-1.

Taguchi T, Shimura M, Osawa Y, Suzuki Y, Mizoguchi I, Niino K, Takaku F, Ishizaka Y.

Biochem Biophys Res Commun. 2004 Jul 16;320(1):18-26.

PMID:
15207696
16.
17.

Analysis of gene expression profiles in an imatinib-resistant cell line, KCL22/SR.

Ohmine K, Nagai T, Tarumoto T, Miyoshi T, Muroi K, Mano H, Komatsu N, Takaku F, Ozawa K.

Stem Cells. 2003;21(3):315-21.

18.

[Expectation on the Japanese Society of Internal Medicine].

Takaku F.

Nihon Naika Gakkai Zasshi. 2002 Dec 10;91(12):3478-9. Japanese. No abstract available.

PMID:
12655690
19.

Clinical usefulness of macrophage colony-stimulating factor for ovarian cancers: Long-term prognosis after five years.

Mizutani K, Takeuchi S, Ohashi Y, Yakushiji M, Nishimura H, Takahashi T, Maruhashi T, Ueda K, Noda K, Watanabe Y, Kawana T, Terashima Y, Ochiai K, Goto S, Takaku F, Motoyoshi K.

Oncol Rep. 2003 Jan-Feb;10(1):127-31.

PMID:
12469157
20.

[Progress in the field of hematology in the last 100 years].

Takaku F.

Nihon Naika Gakkai Zasshi. 2002 Jul 10;91(7):1968-70. Japanese. No abstract available.

PMID:
12187658
21.

Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study.

Usuki K, Urabe A, Masaoka T, Ohno R, Mizoguchi H, Hamajima N, Miyazaki T, Niitsu Y, Yoshida Y, Miura A, Shibata A, Abe T, Miura Y, Ikeda Y, Nomura T, Nagao T, Saitou H, Shirakawa S, Ohkuma M, Matsuda T, Nakamura T, Horiuchi A, Kuramoto A, Kimura I, Irino S, Niho Y, Takatsuki K, Tomonaga M, Uchino H, Takaku F; Gran AML Study Group.

Br J Haematol. 2002 Jan;116(1):103-12.

PMID:
11841402
22.
23.

Tyrosine phosphorylation of proteins in primary human myeloid leukemic cells stimulated by macrophage colony-stimulating factor: analysis by disease type and comparison with normal human hematopoietic cells.

Hagiwara S, Yagisawa M, Saeki K, Iki S, Urabe A, Mimura T, Miwa A, Togawa A, Higashihara M, Takaku F, Yuo A.

Int J Hematol. 2001 Jan;73(1):100-7.

PMID:
11372744
24.

[Medicine in 21st century: contribution of hematology to advanced medicine].

Takaku F.

Rinsho Ketsueki. 2001 Feb;42(2):63-7. Japanese. No abstract available.

PMID:
11280918
25.
26.

[Overview on the millennium genome project].

Takaku F.

Nihon Rinsho. 2001 Jan;59(1):11-8. Review. Japanese.

PMID:
11197839
27.

Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemic HL60 cells.

Saeki K, Yuo A, Okuma E, Yazaki Y, Susin SA, Kroemer G, Takaku F.

Cell Death Differ. 2000 Dec;7(12):1263-9.

28.

[Present states and future perspectives of advanced medicine].

Takaku F.

Tanpakushitsu Kakusan Koso. 2000 Sep;45(13 Suppl):2320-4. Review. Japanese. No abstract available.

PMID:
11021242
29.

[Long-term follow up of chronic myelogenous leukemia patients treated with natural interferon alpha--multi-institutional cooperative study].

Urabe A, Asano S, Mizoguchi H, Aoki N, Takaku F.

Gan To Kagaku Ryoho. 2000 Sep;27(10):1541-6. Japanese.

PMID:
11015999
30.

Oxidative stress as a necessary factor in room temperature-induced apoptosis of HL-60 cells.

Shimura M, Osawa Y, Yuo A, Hatake K, Takaku F, Ishizaka Y.

J Leukoc Biol. 2000 Jul;68(1):87-96.

PMID:
10914494
31.

[Hematology].

Takaku F.

Nihon Rinsho. 2000 Apr;58(4):962-8. Japanese. No abstract available.

PMID:
10885967
32.

Improved gene transfer to neuroblastoma cells by a monoclonal antibody targeting RET, a receptor tyrosine kinase.

Yano L, Shimura M, Taniguchi M, Hayashi Y, Suzuki T, Hatake K, Takaku F, Ishizaka Y.

Hum Gene Ther. 2000 May 1;11(7):995-1004.

PMID:
10811228
33.

[Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases].

Urabe A, Fujita A, Aoki K, Koike M, Kitamura K, Ohbayashi Y, Oshimi K, Wakabayashi Y, Kuraishi Y, Kurihara I, Togawa A, Hoshino S, Ozawa K, Hotta T, Higashihara M, Nagoshi H, Hirai H, Omine M, Asano S, Nishimura M, Suzuki K, Bessho M, Mizoguchi H, Furusawa S, Nonaka Y, Takaku F.

Jpn J Antibiot. 2000 Feb;53(2):61-74. Japanese.

PMID:
10786314
34.

[Evidence-based medicine: present status and problems in our country].

Takaku F.

Hokkaido Igaku Zasshi. 2000 Jan;75(1):3-7. Japanese.

PMID:
10736755
35.

[Clinical evaluation of rhG-CSF in patients with neutropenia induced by chemotherapy for multiple myeloma].

Togawa A, Mizoguchi H, Toyama K, Urabe A, Ohasi Y, Takaku F.

Rinsho Ketsueki. 2000 Feb;41(2):115-22. Japanese.

PMID:
10723240
36.

[A multicenter early phase II study of high-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of intermediate-grade non-Hodgkin's lymphoma. Japan Blood Cell Transplantation Study Group].

Chou T, Ishiguro T, Imajo K, Kawano F, Gondo H, Kasai M, Masuda M, Koike M, Shimazaki C, Hara M, Shinagawa K, Ogawa M, Takaku F, Harada M.

Rinsho Ketsueki. 1999 Oct;40(10):1058-67. Japanese.

PMID:
10565222
37.

[An early phase II study of autologous peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission. Japan Blood Cell Transplantation Study Group].

Kawano F, Kiyokawa T, Shinagawa K, Takenaka K, Imajo K, Hayashi S, Hirota Y, Ohno H, Tsuda H, Gondo H, Shibuya T, Hisano S, Harada M, Ogawa M, Takaku F.

Rinsho Ketsueki. 1999 Oct;40(10):1051-7. Japanese.

PMID:
10565221
38.

Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia.

Kodera Y, Morishima Y, Kato S, Akiyama Y, Sao H, Matsuyama T, Kawa K, Sakamaki H, Nakagawa S, Hirabayashi N, Dohi H, Okamoto S, Hiraoka A, Gondo H, Tsuchida M, O H, Harada M, Asano S, Juji T, Sasazuki T, Takaku F.

Bone Marrow Transplant. 1999 Nov;24(9):995-1003.

39.

Human platelet alloantigen (HPA)-5a/b mismatch decreases disease-free survival in unrelated bone marrow transplantation.

Juji T, Watanabe Y, Ishikawa Y, Fujiwara K, Tonami H, Tanaka H, Satake M, Akaza T, Tadokoro K, Kodera Y, Sasazuki T, Morishima Y, Takaku F.

Tissue Antigens. 1999 Sep;54(3):229-34.

PMID:
10519359
40.

Aberrant expression of cAMP-response-element-binding protein ('CREB') induces apoptosis.

Saeki K, Yuo A, Suzuki E, Yazaki Y, Takaku F.

Biochem J. 1999 Oct 1;343 Pt 1:249-55.

41.

Inhibition of Vpr-induced cell cycle abnormality by quercetin: a novel strategy for searching compounds targeting Vpr.

Shimura M, Zhou Y, Asada Y, Yoshikawa T, Hatake K, Takaku F, Ishizaka Y.

Biochem Biophys Res Commun. 1999 Aug 2;261(2):308-16.

PMID:
10425183
42.

Room temperature-induced apoptosis of Jurkat cells sensitive to both caspase-1 and caspase-3 inhibitors.

Shimura M, Okuma E, Yuo A, Sasaki T, Mukai C, Takaku F, Ishizaka Y.

Cancer Lett. 1998 Oct 23;132(1-2):7-16.

PMID:
10397447
43.
44.

Micronuclei formation with chromosome breaks and gene amplification caused by Vpr, an accessory gene of human immunodeficiency virus.

Shimura M, Onozuka Y, Yamaguchi T, Hatake K, Takaku F, Ishizaka Y.

Cancer Res. 1999 May 15;59(10):2259-64.

45.

fcsA29 mutation is an allele of polA gene of Escherichia coli.

Nagano K, Wachi M, Takada A, Takaku F, Hirasawa T, Nagai K.

Biosci Biotechnol Biochem. 1999 Feb;63(2):427-9.

46.

Micronuclei formation and aneuploidy induced by Vpr, an accessory gene of human immunodeficiency virus type 1.

Shimura M, Tanaka Y, Nakamura S, Minemoto Y, Yamashita K, Hatake K, Takaku F, Ishizaka Y.

FASEB J. 1999 Apr;13(6):621-37.

PMID:
10094923
49.

Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.

Sasazuki T, Juji T, Morishima Y, Kinukawa N, Kashiwabara H, Inoko H, Yoshida T, Kimura A, Akaza T, Kamikawaji N, Kodera Y, Takaku F.

N Engl J Med. 1998 Oct 22;339(17):1177-85. Erratum in: N Engl J Med 1999 Feb 4;340(5):402.

50.

Allogeneic peripheral blood stem cell transplantation for standard-risk leukemia. A multicenter pilot study: Japanese experience. Japan Blood Cell Transplantation Study Group.

Harada M, Shinagawa K, Kawano T, Kasai M, Sawada H, Nakao S, Hyodo H, Aotsuka N, Furukawa T, Hirai H, Eto T, Imai Y, Shimazaki C, Matsue K, Ogawa M, Takaku F.

Bone Marrow Transplant. 1998 Jun;21 Suppl 3:S54-6.

PMID:
9712495

Supplemental Content

Loading ...
Support Center